Jeff Sharman
MD
Medical Director, Hematology Research
👥Biography 个人简介
Jeff Sharman is a leading community-based CLL researcher who has contributed to the development of acalabrutinib through the ELEVATE trial program. His research has demonstrated the efficacy and tolerability of next-generation BTK inhibitors in treatment-naive CLL. He advocates for integrating novel therapies into community oncology practice.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jeff Sharman 的研究动态
Follow Jeff Sharman's research updates
留下邮箱，当我们发布与 Jeff Sharman（Willamette Valley Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment